Medicare Enrolled

Dr. Edward Pearson, MD

Internal Medicine · Dallas, TX
Practice pattern: Mixed Practice— Diverse clinical practice across multiple procedure types
Speaking/Promotional
3410 WORTH ST STE 400, Dallas, TX 75246
2143701000
In practice since 2011 (14 years)
NPI: 1801188172 verify on NPPES ↗
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Pearson from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Pearson? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. Pearson

Dr. Edward Pearson is an internal medicine in Dallas, TX, with 14 years in practice. Based on federal Medicare data, Dr. Pearson performed 47,188 Medicare services across 3,345 unique beneficiaries.

Between the years covered by Open Payments, Dr. Pearson received a total of $726,673 from 62 pharmaceutical and/or device companies across 943 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in internal medicine. The majority of payments are for speaking programs and promotional activities, reflecting participation in industry-sponsored events. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. Pearson is Very High — reflecting how much public federal data is available about this provider. This is not a quality rating. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 14 years in practice▲ Top 1% volume in TX$ $726,673 industry payments

Medicare Practice Summary

Medicare Utilization ↗
47,188
Medicare services
Top 1% in TX for internal medicine
3,345
Unique beneficiaries
$12
Avg. Medicare payment
Medicare patients only (65+ / disabled) · Not a quality rating · How to read this →
~3,371 Medicare services per year of practice

Top procedures by volume

Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.

ProcedureVolumeAvg. paidAvg. submitted
Darbepoetin injection (Aranesp) for anemia14,980$2$20
Pembrolizumab injection (Keytruda)7,400$43$136
Anti-nausea injection (fosaprepitant)5,400$0$5
Paclitaxel chemotherapy injection5,322$0$8
Contrast dye for imaging (iodine-based)3,981$0$3
Dexamethasone injection (steroid)1,004$0$1
Comprehensive metabolic blood panel964$10$64
Lactate dehydrogenase (enzyme) level939$6$31
Blood draw (venipuncture)916$8$20
Complete blood count (CBC) with differential890$8$36
Anti-nausea injection (Aloxi/palonosetron)620$1$114
Measurement of immunoglobulin light chains522$17$60
Office visit, established patient (30-39 min)471$94$368
Injection, granisetron hydrochloride, 100 mcg420$0$24
Ferritin level test (iron stores)267$13$60
Iron level test265$6$27
Iron binding capacity test265$9$35
Office visit, established patient (20-29 min)246$61$250
Infusion into a vein for therapy, prevention, or diagnosis, additional sequential infusion, 1 hour or less201$23$157
Complete blood count (CBC), automated190$6$34
Microscopic examination for white blood cells with manual cell count186$4$22
Drug injection, under skin or into muscle169$11$96
Administration of chemotherapy into vein, 1 hour or less164$105$707
Injection, carboplatin, 50 mg158$2$300
Injection of additional new drug or substance into vein151$12$108
Office visit, established patient, complex (40-54 min)141$137$496
Injection, fluorouracil, 500 mg112$2$13
Reticulated (young) platelet measurement91$35$143
Hospital follow-up visit, high complexity85$94$357
Immunoglobulin level test75$9$56
Injection, diphenhydramine hcl, up to 50 mg61$1$7
Hospital follow-up visit, moderate complexity53$62$247
New patient office visit, complex (60-74 min)50$168$709
Unclassified drugs47$1$8
Administration of additional new drug or substance into vein, 1 hour or less41$52$344
Ct scan of chest with contrast38$58$821
Uric acid level test36$4$25
Administration of chemotherapy into vein, each additional hour34$23$161
Infusion into a vein for therapy, prevention, or diagnosis, 1 hour or less32$51$313
CT scan of abdomen and pelvis with contrast31$184$1,067
Administration of non-hormonal anti-neoplastic chemotherapy under skin or into muscle28$56$211
Infusion into a vein for therapy, prevention, or diagnosis concurrent with another infusion20$16$94
Fluorodeoxyglucose f-18 fdg, diagnostic, per study dose, up to 45 millicuries20$86$657
Infusion, normal saline solution , 1000 cc20$2$19
Red blood count, automated test17$4$23
Nuclear medicine study from skull base to mid-thigh with ct scan14$1,103$4,802
Infusion into a vein for therapy, prevention, or diagnosis, each additional hour14$15$100
Administration of chemotherapy into vein using push technique14$81$500
X-ray of upper arm, minimum of 2 views12$20$67
Complete x-ray of body bones11$54$207
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
0.6% high complexity
85.0% medium
14.4% routine

Industry Payment Transparency

Open Payments through 2024 ↗
$726,673
Total received (2018-2024)
Avg $103,810/year across 7 years
Top 0% in TX for internal medicine
62
Companies
943
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →

Payment profile

Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.

Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$593,682 (81.7%)
Consulting
Expert advisory fees, typically reflecting recognized clinical expertise
$125,646 (17.3%)
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$7,346 (1.0%)

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2024
$202,256
2023
$206,621
2022
$144,636
2021
$95,592
2020
$55,394
2019
$15,180
2018
$6,994

Payments by company (2024)

Consulting
Speaking
Meals & Travel
Research
GENZYME CORPORATION
$206,839
AstraZeneca Pharmaceuticals LP
$127,252
E.R. Squibb & Sons, L.L.C.
$68,437
PharmaEssentia USA Corporation
$50,423
Adaptive Biotechnologies Corporation
$32,449
Astellas Pharma US Inc
$26,784
GlaxoSmithKline, LLC.
$26,127
Rigel Pharmaceuticals, Inc.
$23,562
Blueprint Medicines Corporation
$21,011
Incyte Corporation
$18,171
Celgene Corporation
$17,118
Genmab U.S., Inc.
$17,049
ABBVIE INC.
$16,623
ADC Therapeutics America, Inc.
$12,676
Lilly USA, LLC
$11,799
SERVIER PHARMACEUTICALS LLC
$7,599
Agios Pharmaceuticals, Inc.
$6,894
Servier Pharmaceuticals LLC
$6,710
Bayer HealthCare Pharmaceuticals Inc.
$4,380
Janssen Biotech, Inc.
$2,853
Karyopharm Therapeutics Inc.
$2,488
Stemline Therapeutics Inc.
$2,425
Hoffmann-La Roche Limited
$2,263
Janssen Scientific Affairs, LLC
$2,020
AbbVie Inc.
$1,800
Seattle Genetics, Inc.
$1,548
Novartis Pharmaceuticals Corporation
$1,526
Epizyme, Inc.,
$1,458
PFIZER INC.
$1,318
NOVARTIS PHARMACEUTICALS CORPORATION
$1,169
BeiGene, Ltd.
$450
Pharmacyclics LLC, An AbbVie Company
$304
Seagen Inc.
$288
Takeda Pharmaceuticals U.S.A., Inc.
$263
Amgen Inc.
$252
BeiGene USA, Inc.
$233
Kite Pharma, Inc.
$226
SANOFI-AVENTIS U.S. LLC
$211
Jazz Pharmaceuticals Inc.
$200
MorphoSys, US Inc.
$164
SOBI, INC
$135
Emmaus Medical, Inc.
$130
CTI BioPharma Corp.
$116
Dova Pharmaceuticals
$93
Acrotech Biopharma LLC
$91
JAZZ PHARMACEUTICALS INC.
$87
Ipsen Biopharmaceuticals, Inc
$70
Siemens Medical Solutions USA, Inc.
$63
Merck Sharp & Dohme LLC
$62
Mirati Therapeutics, Inc.
$59
RECORDATI_RARE_DISEASES_INC.
$57
Regeneron Healthcare Solutions, Inc.
$55
Genentech USA, Inc.
$52
Genentech, Inc.
$50
Daiichi Sankyo Inc.
$46
Sobi, Inc
$41
Legend Biotech USA Inc.
$25
Apellis Pharmaceuticals, Inc.
$24
Acrotech Biopharma Inc.
$17
Taiho Oncology, Inc.
$14
Acceleron Pharma, Inc.
$13
Gilead Sciences, Inc.
$12
Top 3 companies account for 55.4% of total payments
Associated products mentioned in payments ›
ABECMA · ADCETRIS · ALPROLIX · AYVAKIT · Aliqopa · BELEODAQ · BESREMI · BLENREP · BOSULIF · BRUKINSA · Blincyto · CABLIVI · CALQUENCE · CARVYKTI · CRESEMBA · DARZALEX · DOPTELET · Doptelet · ELIQUIS · ELITEK · ELREXFIO · ELZONRIS · ENJAYMO · EPKINLY · Empaveli · Endari · Epkinly · GAMIFANT · Gamifant · ICLUSIG · IMBRUVICA · Imbruvica · JAKAFI · JAYPIRCA · KEYTRUDA · KRAZATI · Kyprolis · LIBTAYO · LONSURF · LYNPARZA · Lunsumio · MONJUVI · MYLOTARG · Molecular Accessories · Molecular Reagents/Test Kit/Clinical Utilization · NINLARO · Neulasta · Non-Covered Product · Nplate · OJJAARA · ONUREG · PROMACTA · Polivy · Pomalyst · REBLOZYL · RETEVMO · REZUROCK · RYBREVANT · Reblozyl · Revlimid · Rezlidhia · SARCLISA · SCEMBLIX · SHINGRIX · SYLVANT · TAGRISSO · TASIGNA · TAZVERIK · TIBSOVO · Tavalisse · Tazverik · Tibsovo · VENCLEXTA · VONJO · VYXEOS · Vanflyta · Vonjo · XOSPATA · XPOVIO · Xospata · Yescarta · ZEPZELCA · clonoSEQ
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →

The majority of payments (82%) are for speaking programs and promotional activities, which reflect participation in industry-sponsored educational or marketing events. This is common in internal medicine and does not inherently indicate bias, but patients may wish to be aware. Total industry engagement is in the top 0% for internal medicine in TX.

Equivalent to $1,540 per 100 Medicare services performed
Looking for a internal medicine in Dallas?
Compare internal medicines in the Dallas area by procedure volume, costs, and industry payment transparency.
Browse internal medicines nearby

Geographic Context

Internal Medicines within 10 mi
2,123
Per 100K population
81.5
County median income
$74,149
Nearest hospital
BAYLOR UNIVERSITY MEDICAL CENTER
0.0 mi

Data Sources

Provider Registry NPPESWeekly updates
Medicare Enrollment PECOSMonthly updates
Practice Data Medicare Util.Annual (CY lag)
Industry Payments Open PaymentsCY 2024
Disciplinary History— Not publicN/A

This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This measures how much public data is available about a provider — not how good they are. How we calculate this →

Summary

Dr. Pearson is a mixed practice specialist, with above-average Medicare volume (top 1% in TX), and high industry engagement (speaking/promotional, top 0%).

This summary is auto-generated from federal data. It describes data availability and patterns — not clinical quality. Read our methodology →

Frequently Asked Questions

Is Dr. Pearson experienced with darbepoetin injection (aranesp) for anemia?
Based on Medicare claims data, Dr. Pearson performed 14,980 darbepoetin injection (aranesp) for anemia services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Pearson receive payments from pharmaceutical companies?
Yes. Dr. Pearson received a total of $726,673 from 62 companies across 943 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Pearson's costs compare to other internal medicines in Dallas?
Dr. Pearson's average Medicare payment per service is $12. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Pearson) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
About this page

All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. The Transparency Score measures data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Payments from industry are legal and do not indicate wrongdoing. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →